First Manhattan CO Gilead Sciences, Inc. Transaction History

First Manhattan CO

  • $31.9 Billion
  • Q3 2024

A detailed history of First Manhattan CO transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, First Manhattan CO holds 67,146 shares of GILD stock, worth $6.15 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
67,146
Previous 71,198 5.69%
Holding current value
$6.15 Million
Previous $4.88 Million 15.23%
% of portfolio
0.02%
Previous 0.02%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$66.59 - $83.99 $269,822 - $340,327
-4,052 Reduced 5.69%
67,146 $5.63 Million
Q2 2024

Aug 13, 2024
SELL
$63.15 - $72.88 $454,806 - $524,881
-7,202 Reduced 9.19%
71,198 $4.88 Million
Q1 2024

May 15, 2024
SELL
$71.58 - $87.29 $425,328 - $518,677
-5,942 Reduced 7.05%
78,400 $5.74 Million
Q4 2023

Feb 13, 2024
SELL
$73.27 - $83.09 $85,799 - $97,298
-1,171 Reduced 1.37%
84,342 $6.83 Million
Q3 2023

Nov 14, 2023
SELL
$73.94 - $80.67 $241,488 - $263,468
-3,266 Reduced 3.68%
85,513 $6.41 Million
Q2 2023

Aug 14, 2023
SELL
$76.01 - $86.7 $543,243 - $619,644
-7,147 Reduced 7.45%
88,779 $6.84 Million
Q1 2023

May 15, 2023
BUY
$77.31 - $88.08 $39,196 - $44,656
507 Added 0.53%
95,926 $7.96 Million
Q4 2022

Feb 14, 2023
SELL
$62.32 - $89.47 $5.97 Million - $8.57 Million
-95,770 Reduced 50.09%
95,419 $8.19 Million
Q3 2022

Nov 14, 2022
SELL
$59.54 - $68.01 $1.01 Million - $1.15 Million
-16,959 Reduced 8.15%
191,189 $11.6 Million
Q2 2022

Aug 15, 2022
SELL
$57.72 - $65.01 $2.65 Million - $2.99 Million
-45,976 Reduced 18.09%
208,148 $12.5 Million
Q1 2022

May 16, 2022
SELL
$57.92 - $72.58 $2.48 Million - $3.11 Million
-42,859 Reduced 14.43%
254,124 $15.1 Million
Q4 2021

Feb 14, 2022
SELL
$64.88 - $73.64 $575,355 - $653,039
-8,868 Reduced 2.9%
296,983 $21.6 Million
Q3 2021

Nov 15, 2021
SELL
$67.69 - $73.03 $20.1 Million - $21.6 Million
-296,426 Reduced 49.22%
305,851 $21.4 Million
Q2 2021

Aug 16, 2021
SELL
$63.47 - $69.35 $11.8 Million - $12.9 Million
-186,551 Reduced 23.65%
602,277 $41.5 Million
Q1 2021

May 14, 2021
SELL
$60.0 - $68.46 $15 Million - $17.1 Million
-250,251 Reduced 24.08%
788,828 $51 Million
Q4 2020

Feb 16, 2021
SELL
$56.65 - $64.55 $10.4 Million - $11.9 Million
-183,885 Reduced 15.04%
1,039,079 $60.5 Million
Q3 2020

Nov 12, 2020
SELL
$62.1 - $78.08 $7.25 Million - $9.11 Million
-116,736 Reduced 8.71%
1,222,964 $77.3 Million
Q2 2020

Aug 14, 2020
BUY
$72.34 - $84.0 $101,058 - $117,348
1,397 Added 0.1%
1,339,700 $103 Million
Q1 2020

May 06, 2020
SELL
$62.63 - $80.22 $21.6 Million - $27.7 Million
-345,648 Reduced 20.53%
1,338,303 $100 Million
Q4 2019

Feb 13, 2020
SELL
$61.62 - $67.78 $8.63 Million - $9.49 Million
-140,016 Reduced 7.68%
1,683,951 $109 Million
Q3 2019

Nov 13, 2019
SELL
$62.51 - $69.0 $10.1 Million - $11.2 Million
-162,196 Reduced 8.17%
1,823,967 $116 Million
Q2 2019

Aug 16, 2019
SELL
$61.87 - $69.38 $7.15 Million - $8.02 Million
-115,554 Reduced 5.5%
1,986,163 $134 Million
Q1 2019

Apr 12, 2019
SELL
$62.53 - $70.05 $5.2 Million - $5.82 Million
-83,082 Reduced 3.8%
2,101,717 $137 Million
Q4 2018

Jan 30, 2019
SELL
$60.54 - $79.0 $25.7 Million - $33.5 Million
-423,711 Reduced 16.24%
2,184,799 $137 Million
Q3 2018

Oct 15, 2018
SELL
$71.28 - $78.92 $7.65 Million - $8.47 Million
-107,318 Reduced 3.95%
2,608,510 $201 Million
Q2 2018

Aug 01, 2018
SELL
$64.88 - $75.68 $1.91 Million - $2.23 Million
-29,423 Reduced 1.07%
2,715,828 $192 Million
Q1 2018

Apr 20, 2018
SELL
$72.84 - $88.8 $2.32 Million - $2.83 Million
-31,887 Reduced 1.15%
2,745,251 $207 Million
Q4 2017

Jan 22, 2018
SELL
$71.15 - $83.52 $1.37 Million - $1.61 Million
-19,270 Reduced 0.69%
2,777,138 $199 Million
Q3 2017

Oct 25, 2017
BUY
$72.11 - $85.47 $202 Million - $239 Million
2,796,408
2,796,408 $227 Million

Others Institutions Holding GILD

# of Institutions
1,925
Shares Held
994M
Call Options Held
10.5M
Put Options Held
9.75M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $115B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track First Manhattan CO Portfolio

Follow First Manhattan CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Manhattan CO, based on Form 13F filings with the SEC.

News

Stay updated on First Manhattan CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email